Developing a Study Budget and Contract - Temple University
Developing a Study Budget and Contract - Temple University
Developing a Study Budget and Contract - Temple University
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Developing</strong> a <strong>Study</strong> <strong>Budget</strong><br />
<strong>and</strong> <strong>Contract</strong><br />
Arleen Wallen<br />
Department Administrative Director<br />
HSC ‐ Office of Clinical Trials<br />
Administration<br />
February 14, 2013
Overview<br />
•Types of Agreements<br />
•Sponsor <strong>Budget</strong>s<br />
•Considerations<br />
•Sample Sponsor <strong>Budget</strong>s<br />
•Sample TU Clinical Trial <strong>Budget</strong>s
Confidentiality Agreements<br />
• A CDA is an agreement between the sponsor <strong>and</strong> the<br />
<strong>University</strong> which allows the sponsor to provide a protocol<br />
to the investigator. It is intended to maintain<br />
confidentiality of the protocol.<br />
• In order to protect the <strong>University</strong> <strong>and</strong> the investigator,<br />
this agreement must be reviewed <strong>and</strong> approved by<br />
OCT/HSC Legal Counsel.<br />
• Clinical Trials Administration will process the CDA on<br />
behalf of the Institution
LOI’s <strong>and</strong> LOA’s<br />
• LOI – Agreement between <strong>University</strong> <strong>and</strong> Sponsor<br />
for Indemnification subject injury protection for<br />
Institution <strong>and</strong> Subject when CRO is signing the CTA<br />
• LOA – Letter of Authority when CRO signing for<br />
Sponsor <strong>and</strong> CTA includes Indemnification <strong>and</strong><br />
subject injury clauses.
CTA – Clinical Trial Agreement<br />
Typical <strong>Contract</strong> Structure<br />
•General Provisions<br />
•Special Provisions<br />
•Miscellaneous Provisions<br />
•Exhibits & Addenda
Who are the SPONSORS?<br />
• Pharmaceutical/Medical Device<br />
Companies<br />
• Biotech Companies<br />
• CRO (<strong>Contract</strong> Research Organization)
Master Agreements (15)<br />
• Abbott Vascular<br />
• Amgen<br />
• Biogen<br />
• Celgene<br />
• Duke Rapid Start<br />
Network<br />
• Genentech (Roche)<br />
• GlaxoSmithKline<br />
• Intermune<br />
• Medtronic<br />
• Merck<br />
• Novo Nordisk<br />
• Novartis<br />
• Sanofi<br />
• Scripps Consortium for<br />
Liver Research<br />
• St. Jude
General Provisions<br />
• Scope of Work: describes the work in<br />
summary form <strong>and</strong> incorporates the <strong>Study</strong><br />
Protocol.<br />
• Personnel: Identify PI & Sub‐investigators<br />
<strong>and</strong> what will be done if PI is no longer<br />
affiliated with institution.<br />
• Term: Length of study either by date or by<br />
completed action required under the<br />
contract.
General Provisions<br />
• Recordkeeping <strong>and</strong> Access: Describe the terms<br />
under which the sponsor will have access to original<br />
study documents <strong>and</strong> to audit (usually normal<br />
business hours with reasonable notice).<br />
• Notice: Who to contact in the event particular info is<br />
needed from either the Institution or the Sponsor<br />
<strong>and</strong> how notice is effectuated.
General Provisions<br />
• Assurances: That the Site meets regulatory<br />
requirements regarding things like Good Clinical<br />
Practices, IRB approval, HIPAA; Use of most recent IC<br />
• Independent <strong>Contract</strong>or: <strong>and</strong> specifically not an<br />
agent of the Sponsor;<br />
• Use of Name: That parties will not use each others<br />
names in any promotional activity with out consent;<br />
pre‐approval for use of website.
Costs <strong>and</strong> Payment Terms<br />
Payment terms<br />
• Incorporated in body of agreement<br />
• Or as Attachment<br />
• Sometimes negotiated with<br />
separate person<br />
• Sometimes requires separate PI<br />
signature
Additional Issues with <strong>Contract</strong>s<br />
• Use of Clinicaltrials.gov Registry<br />
• IC<br />
• Insurance<br />
• Choice of Governing Law<br />
• Sufficient Payment for Overhead, Coordinator,<br />
<strong>and</strong> Hidden Expenses
ClinicalTrials . Gov<br />
Listing in ClinicalTrials.gov. now required by law<br />
Stephanie Brictson (2-9190) can assist with Registering<br />
Non-Industry sponsored trials
Sample Publication Clauses<br />
• Sponsor shall (without written authorization)<br />
allow Institution to list the <strong>Study</strong> title,<br />
Sponsor’s name <strong>and</strong> Participating Investigator<br />
on the Institution’s website (to encourage<br />
patient enrollment).
Miscellaneous Provisions<br />
• Governing/Controlling law<br />
• Amendments & Severability<br />
• Assignment<br />
• Return of drugs/devices<br />
• Record retention for “x” years<br />
• Debarment warranty<br />
• Alternative Dispute Resolution
Exhibits/Amendments<br />
• Itemized cost breakdown<br />
• Schedule of payments<br />
• Protocol –by reference<br />
• Investigator’s Agreement/Acknowledgement<br />
• LOI – Letter of Indemnification
Costs <strong>and</strong> Payment Terms<br />
• Cost <strong>and</strong> payment terms of the<br />
contract<br />
• Start‐up costs (non‐refundable, administrative)<br />
• incentives (enrollment & time targets)<br />
• administrative fees (institutional overhead)<br />
• infrastructure costs (IRB, advertising,<br />
pharmacy, radiology set up)<br />
• In the event of early termination what will be<br />
paid for work completed <strong>and</strong> obligated costs?
Costs <strong>and</strong> Payment Terms<br />
• Cost <strong>and</strong> payment terms (continued)<br />
• Location <strong>and</strong> Payee Information<br />
• Payment Schedule (Usually separate)<br />
• Per Subject Fee<br />
• Screen Failure<br />
• Optional payments<br />
• Additional fees ( Translation, SAE’s,<br />
Monitoring, Closeout)
Sample Payment terms<br />
Visits/Procedures Completed:<br />
• Baseline $880.10<br />
• Week 1 $795.60<br />
• Week 2 $2,214.10<br />
• Week 3 $711.10<br />
• Week 6 $2,090.50<br />
• Week 12 $425.10
Sample Payment Terms<br />
• Variable Patient Fees.<br />
Screen Failure Fee. ….a rate of ONE THOUSAND, SIX<br />
HUNDRED SEVENTY‐FIVE DOLLARS ($1,675) per patient, up to<br />
a maximum of two (2) screen failures for every seven (7)<br />
Evaluable Patients<br />
• CT Scan Fee. …on a pass through basis, for the actual <strong>and</strong><br />
reasonable cost of any <strong>Study</strong> related CT scans performed at<br />
Visit 12 …Under no circumstances will CT Scan Fee<br />
reimbursement exceed ONE THOUSAND, TWO HUNDRED<br />
DOLLARS ($1,200.00). Institute shall provide …with all<br />
necessary documentation in support of the CT Scan Fees.
<strong>Budget</strong> Samples<br />
• Imbedded <strong>Budget</strong><br />
• Total by procedures<br />
• Spreadsheet by visit<br />
• Appendix Payment Schedule/<strong>Budget</strong>
Imbedded<br />
MDP, on behalf of Sponsor, agrees to<br />
provide financial support for ACHD QuERI<br />
in the amount of one thous<strong>and</strong> <strong>and</strong> two<br />
hundred dollars ($1,200.00) (U.S. Dollars)<br />
per evaluable subject according to Exhibit<br />
B (hereinafter known as “<strong>Budget</strong>”), the<br />
terms of which are incorporated herein <strong>and</strong><br />
made a part of this Agreement. Payments<br />
will be provided quarterly <strong>and</strong> will be based<br />
on the number of subject case report forms<br />
that have been completed for subject visits,<br />
as described in <strong>Budget</strong>, in a given quarter.
Sample by Visit<br />
Visits Completed:<br />
• Baseline $ 880.10<br />
• Week 1 $ 795.60<br />
• Week 2 $ 2,214.10<br />
• Week 3 $ 711.10<br />
• Week 6 $ 2,090.50<br />
• Week 12 $ 425.10
Spread sheet by Frequency<br />
Procedure Description Cost Frequency Cost/Patient<br />
IC 60 1 60<br />
Hist/Phys <strong>and</strong> pelvic1 (enrollment) 250 1 250<br />
Hist/Phys <strong>and</strong> pelvic (3 visits) 150 3 450<br />
Urine Pregnancy Test 35 1 35<br />
Trichomonas 70 1 70<br />
Chlamydia trachomatis DNA test 70 1 70<br />
Neisseria Gonorrhoeae DNA test 70 1 70<br />
Blood test at each visit to test for copper levels GoldenCare Group 31 4 124<br />
Vaginal yeast culture2 73.5 4 294<br />
H<strong>and</strong>ling fee 60 4 240<br />
CRF completion <strong>and</strong> diary review 50 4 200<br />
Patient incentive – visit 1, visit 2 25 2 50<br />
Patient incentive – visit 3, visit 4 50 2 100<br />
Colposcopy Examination for GoldenCare Group 350 3 1050<br />
SubTotals 3063<br />
Totals inc. 35% institutional overhead 4135.05
Spread Sheet by Procedure<br />
Day 1 2‐7 180 194<br />
Hospital<br />
Phone visit<br />
Procedure Hospital Admission Admission stay discharge Clinic Visit 2 5 TOTAL<br />
Informed Consent $74 $74<br />
Medical HX $74 $74<br />
Inclusion/Exclusion $0<br />
Full Physical Exam $147 $147<br />
Vitals & Weight $0<br />
Medication history $30 $30 $30 $90<br />
Smoking history $0<br />
Blood Tests<br />
Lab Collection <strong>and</strong><br />
$53 $53 $106<br />
Processing $5 $5 $10<br />
Urine Pregnancy Test $13 $13 $26<br />
Total $322 $0 $104 $101 $0 $527<br />
35% Overhead $112.82 $0.00 $36.40 $35.35 $0.00 $184.57<br />
TOTAL PROJECT COST $435 $0 $140 $136 $0 $712
How to calculate a clinical trial<br />
budget?<br />
• Starts with procedures of the project
Sample Schedule of Events<br />
<strong>Study</strong> Procedures Table Screening Visit 1 Visit 2<br />
Consent x<br />
Physical Exam x x x x<br />
Vitals x x x x<br />
Concomitant Medication x x x<br />
Serum Pregnancy Test x x x<br />
Chemistry Profile x<br />
Hematology Profile x x x x<br />
Drug Accountability x x x<br />
Adverse Events x x x x<br />
Looks like spread sheet without prices<br />
Early<br />
<strong>Study</strong><br />
D/C
St<strong>and</strong>ard Calculations (by OCT)<br />
• Coordinator Time (for per subject fee) ‐ % effort<br />
• 5 hrs for screening visit to cover pre‐screening unless paid<br />
separately<br />
• 1 –2 hr additional per visit for sample processing if<br />
required<br />
• Add up time for questionnaires<br />
• Generally 1 hr for visit plus additional time for drug<br />
administration/monitoring if required<br />
• 40 hrs. for pre‐study work/ total number of subjects<br />
• 5 monitoring visits @ 8 hrs ea / number of subjects per<br />
year
Estimation of time –Other activities to<br />
• Pre‐study activities<br />
include<br />
• Site Qualification Visit<br />
• Attend Investigator Meeting<br />
• IRB application preparation<br />
• <strong>Budget</strong> submission (if completing it)<br />
• Process other regulatory documents
<strong>Study</strong> activities<br />
• <strong>Study</strong> initiation visit<br />
• Recruit subjects<br />
• Conduct staff in services<br />
• Screen subjects<br />
• Consent subjects/guardian<br />
• Schedule subjects<br />
• Administer trial medications
• PI time<br />
St<strong>and</strong>ard Calculations<br />
• 1 hr for IRB submission/review<br />
• 1 hr for IC<br />
• 1 hr first physical<br />
• ½hr each additional physical<br />
• ¼hr for just signing off CRF per visit<br />
• Additional time as needed for procedures
St<strong>and</strong>ard requests when starting Industry<br />
Negotiations<br />
• Non‐refundable administrative start up fee<br />
• St<strong>and</strong>ard ‐ $5,000<br />
• Registry study ‐ $2,500<br />
• Pharmacy set up fee $2,000 (includes both start up ($1,500<br />
<strong>and</strong> $500 close out)<br />
• $250‐$500 Radiology or Laboratory start up fee if numerous<br />
procedures or considerable set up work<br />
• $100 per SAE at our institution <strong>and</strong> $50 per IND safety report<br />
• $2,500 record storage fee<br />
• $60 per hour for monitor visits with coordinator or $250 per<br />
visit
IRB fees – Industry Funded only<br />
• External IRB (WIRB) paid directly including translations;<br />
$2000 for translations estimated<br />
• Local IRB fees<br />
– $2,800 for the initial review<br />
– $1,200 Each annual review<br />
– $490 each change/amendment/external request<br />
• Administrative IRB review fees when sponsor pays WIRB<br />
directly<br />
– Initial Review ‐ $500<br />
– Annual Review ‐ $200<br />
– Each amendment or change $100
Internal <strong>Budget</strong> ‐ Industry<br />
• Time of Coordinator, PI<br />
• Procedure Costs<br />
• Patient Stipend<br />
• Supplies<br />
• Miscellaneous/Residual (Final <strong>Budget</strong> only)<br />
• OCT fee ‐ 10% of Direct or 8.3% of total<br />
• Direct total<br />
• <strong>University</strong> Overhead –20% of Direct Total –or 16.7% of total<br />
• Total – [Per Subject plus allocated start up fee] * [# subjects]
Internal <strong>Budget</strong> of Costs<br />
Item Notes/# CPT Hosp. TUP Per subject 50 Subjects<br />
Coordinator - hrs 15 50 $750.00 $37,500.00<br />
PI - hrs 2 100 $200.00 $10,000.00<br />
Chest X ray 2 71030 $53.63 $16.67 $140.60 $7,030.00<br />
Supplies $5.00 $250.00<br />
Record Storage $10.00 $500.00<br />
Patient Stipend $10.00 $500.00<br />
Subtotal $1,115.60 $55,780.00<br />
Miscellaneous $384.40 $19,220.00<br />
OCT 10% $166.67 $8,333.33<br />
Direct $1,666.67 $83,333.33<br />
F&A 20% $333.33 $16,666.67<br />
Total $2,000.00 $100,000.00
Clinical Procedures: Research only<br />
• Industry Funded Trials<br />
• 150% of Medicare rate; $50 separate surcharge<br />
for MRI’s, Scans, to cover additional work <strong>and</strong><br />
measurements<br />
• Grants/ Federal, Unfunded Department<br />
Research<br />
• [Hospital current charge master] * [agreed upon<br />
percentage in federal negotiated rate sheet]<br />
• On‐Line (Research Accounting Services)
Internal <strong>Budget</strong> of Costs<br />
Item Notes/# CPT Hosp. TUP Per subject 50 Subjects<br />
Coordinator - hrs 15 50 $750.00 $37,500.00<br />
PI - hrs 2 100 $200.00 $10,000.00<br />
Chest X ray 2 71030 $53.63 $16.67 $140.60 $7,030.00<br />
Supplies $5.00 $250.00<br />
Record Storage $10.00 $500.00<br />
Patient Stipend $10.00 $500.00<br />
Subtotal $1,115.60 $55,780.00<br />
Miscellaneous $384.40 $19,220.00<br />
OCT 10% $166.67 $8,333.33<br />
Direct $1,666.67 $83,333.33<br />
F&A 20% $333.33 $16,666.67<br />
Total $2,000.00 $100,000.00
Final Internal <strong>Budget</strong><br />
Item Notes/# CPT Hosp. TUP Per subject 50 Subjects<br />
Coordinator - hrs 15 50 $750.00 $37,500.00<br />
PI - hrs 2 100 $200.00 $10,000.00<br />
Chest X ray 2 71030 $53.63 $16.67 $140.60 $7,030.00<br />
Supplies $5.00 $250.00<br />
Record Storage $10.00 $500.00<br />
Patient Stipend $10.00 $500.00<br />
Subtotal $1,115.60 $55,780.00<br />
Miscellaneous $384.40 $19,220.00<br />
OCT 10% $166.67 $8,333.33<br />
Direct $1,666.67 $83,333.33<br />
F&A 20% $333.33 $16,666.67<br />
Total $2,000.00 $100,000.00
Additional study activities<br />
• Maintain drug accountability documentation<br />
• Vital signs<br />
• Obtain/Process lab specimens<br />
• Interview (AE assessment, diaries, questionnaires)<br />
• CRF Forms<br />
• Preparing source document forms<br />
• Enter data into electronic data system
Additional study activities<br />
• Resolve data queries<br />
• Coordinate/Attend monitoring visits<br />
• Monitor/Code/Interpret SAE forms<br />
• IRB correspondence<br />
• Protocol amendments<br />
• Sponsor correspondence<br />
• Update regulatory documents<br />
• Monitor payments from sponsor<br />
• Coordinate/attend study termination visit
Hidden activities:<br />
• Clarification of protocol<br />
• Telephone patient screening<br />
• Communicating with referral sources<br />
• Preparing <strong>and</strong> faxing enrollment<br />
• Receiving <strong>and</strong> managing clinical supplies<br />
• Processing stipend checks<br />
• Rescheduling subject visits
Coordinator/PI Role<br />
• Identify for OCT if time estimates seem<br />
incorrect
Pharmacy Charges<br />
Included in Internal <strong>and</strong> Negotiated <strong>Budget</strong><br />
• R<strong>and</strong>omization<br />
• Administration<br />
• Drug<br />
• Inventory<br />
• Close out if not in start up
eSPAF –for Industry Trials<br />
• Requested when project received so not waiting<br />
when hard copies received; we will change budget<br />
• Need to process agreement for signature<br />
• Direct, Indirect <strong>and</strong> Total budgets usually highlighted<br />
in yellow on Internal budget<br />
• Attach Internal <strong>Budget</strong> sent to you if done after<br />
completion of negotiations<br />
• For Industry trials –don’t need all PI’s on eSPAF to<br />
process for signature. Need PI, Administrator <strong>and</strong><br />
Chair<br />
• Always clinical trials contract; 20% overhead –F&A<br />
• Unless $0 budget
Grant Projects<br />
• Same Considerations but need to know the<br />
difference between:<br />
• Direct costs<br />
• Modified Direct Costs<br />
• Indirect costs<br />
• Total Costs<br />
• Indirect rate: FY 2013 – 54%<br />
FY 2014 – 55%
Determinantion of Staffing <strong>and</strong><br />
Percent Efforts<br />
• First year or start‐up time<br />
• F/U years or study implementation years<br />
• Last year or close out period
Other categories of expense<br />
• Office Supplies<br />
• Equipment<br />
• Postage<br />
• Photocopy/Printing<br />
• Patient Care Costs –Clinical procedures<br />
• <strong>Study</strong> Start‐up <strong>and</strong> close out fees<br />
• Monitoring in IND or IDE studies
Other considerations cont.:<br />
• Professional Meetings <strong>and</strong> Travel<br />
• Patient Incentives <strong>and</strong> Reimbursements<br />
• Software<br />
• Computing Costs<br />
• Consultants
<strong>Study</strong> Timeline Example<br />
Task<br />
Finalize <strong>Study</strong><br />
Protocol/Irb<br />
Approval x<br />
Hire <strong>and</strong> Train<br />
Personnel x<br />
Develop CRF's <strong>and</strong><br />
<strong>Study</strong> Manuals x<br />
Year 1 Year 2 Year 3<br />
Develop <strong>Study</strong><br />
Database<br />
Recruitment <strong>and</strong><br />
x<br />
R<strong>and</strong>omization<br />
Intervention<br />
x x<br />
Implementation<br />
Data Collection at<br />
x x<br />
<strong>Study</strong> Visits x x<br />
Data cleaning x x x<br />
DSMB<br />
Meetings/Reports<br />
Final analysis <strong>and</strong><br />
x x x<br />
Manuscripts x
Grant Year (Y1, Y2, etc) Y1 Y2 Y3 Y4 Y5<br />
Account Description<br />
Fringe<br />
Rate<br />
Account<br />
Expense<br />
Code<br />
Full Time Faculty Salaries 33.1% 6001 $ 106,761 $ 109,964 $ 113,263 $ 116,661 $ 120,161<br />
AY Faculty Salaries (Main Campus Faculty) 33.1% 6001 $ ‐<br />
Full Time Technical Professional 33.1% 6520 $ 45,788 $ 47,161 $ 48,576 $ 50,033 $ 51,534<br />
Part Time Faculty Salary 8.4% 6201 $ ‐<br />
Clinical Faculty 19.6% 60xx $ ‐<br />
Part Time Technical Professional 8.4% 6620 $ ‐<br />
Full Time Administrative Salaries 33.1% 6500 $ ‐<br />
Full Time Clerical Salaries 33.1% 6550 $ ‐<br />
Part Time Clerical Salaries 8.4% 6650 $ ‐<br />
Post Doc 27.3% 6580 $ 41,076 $ 42,309 $ 43,578 $ 44,885 $ 46,232<br />
Visiting Scholar 6660 $ ‐<br />
FT Temporary Salaries 0.0% 6672 $ ‐<br />
TA/GA Salaries 23.0% 63xx $ ‐<br />
Student Workers/Workstudy 0.0% 67xx $ ‐<br />
Fringe Benefits 6990 $ 61,707 $ 63,559 $ 65,465 $ 67,429 $ 69,452<br />
Consultants 7305
Office Supplies 7208<br />
Publications 7375<br />
General Supplies (Lab) 7200<br />
Chemicals for Lab Tests 7251<br />
Computer Software 7201<br />
Computer Equipment < $5,000 7218<br />
Telephone Services 7421<br />
Travel ‐ Domestic 7500<br />
Travel ‐ Foreign 7505<br />
Food 7602<br />
Participant Support 7357<br />
Data Communications 7424<br />
Equipment Expendable < $5000 7214<br />
Animal Purchase 7264<br />
Animal Care & Use 7151<br />
Drugs 7255<br />
Shared Resources 7159<br />
Subcontracts ≤ $25,000 7386<br />
Miscellaneous 7600<br />
Sub‐Total<br />
F&A Costs (Indirect): Adjust formula according to rate(s) effective during period of award 7623<br />
Equipment‐Fixed >$5,000 7880<br />
Equipment‐Movable > $5,000 7870<br />
Subcontracts > $25,000 7387<br />
Patient Care Costs 7150<br />
Tuition 7611<br />
Total
<strong>Budget</strong>ing for a Clinical Trial<br />
• Develop budget based on actual costs<br />
• Develop budget for recovery of all costs <strong>and</strong><br />
at a reasonable margin<br />
• Consider Delayed Cash Flow in Industry Trials<br />
–i.e. 10% holdback till the end of the trial.
Questions